![Patrice Garnier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrice Garnier
Directeur/Membre du Conseil chez Meletios Therapeutics SAS
Postes actifs de Patrice Garnier
Sociétés | Poste | Début | Fin |
---|---|---|---|
Meletios Therapeutics SAS
![]() Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Patrice Garnier
Statistiques
Internationale
France | 2 |
Opérationnelle
Director/Board Member | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Meletios Therapeutics SAS
![]() Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021. | Health Technology |
- Bourse
- Insiders
- Patrice Garnier
- Expérience